Parmax Pharma inks pact with CHL for production of intermediates of ‘Hydroxy chloroquine’

27 Apr 2020 Evaluate

Parmax Pharma has entered into Confidentiality Agreement with Cadila Healthcare (CHL), Ahmedabad for production of intermediates of ‘Hydroxy chloroquine’ (Product) on the basis of process and specifications provided by the CHL. Currently, company is reviewing the business and taking trial batches of the product.

Parmax Pharma carries on business as manufacturers, producers, refiners, mixers, processors, repackers, distillers, formulators, convertors, extractors, buyers, sellers, wholesalers, retailers, distributors, suppliers, importers, extractors, or otherwise to deal in all kinds of drug and drugs used in pharmaceutical.

Parmax Pharma Share Price

34.75 0.28 (0.81%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×